Searched for
NON BIOLOGY DOCTOR
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Could a simple blood test predict depression before symptoms appear? Here's what scientists claimA new blood test tracking immune cell aging may offer an objective way to detect depression before symptoms manifest. Research indicates th...
The ticking price tag: What delaying parenthood really costs you financially and biologicallyA growing number of couples are choosing to delay parenthood in pursuit of career milestones, financial stability, and personal goals. But ...
Scientists discover ancient Antarctic fish fossil with a perfectly preserved skullA remarkable fish fossil from Antarctica offers a clear view of early evolution. Koharalepis jarviki, a 380-million-year-old specimen, reve...
Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
His treadmill test result was normal. 6 weeks later he had a heart attack. CMC Vellore doctor shares what went wrongA normal treadmill stress test can offer false reassurance, as a recent case revealed. A 55-year-old man with intermittent chest discomfort...
Legislative dignity for Harish Ranas: The legal journey shaping India’s right to die debateIndia's journey towards the right to die with dignity has seen major milestones. The Harish Rana case marks a significant step, applying th...
Mankind Pharma targets early Semaglutide launchMankind Pharma is set to enter India's semaglutide market soon. The drug's patent expires this month, opening doors for new players. Mankin...
Budget 2026: Max Healthcare, Apollo Hospitals, other stocks rise up to 4% as FM boosts medical tourismIndian healthcare stocks surged following the Union Budget 2026 announcement of measures to boost medical tourism. The government plans to ...
Will Bryan Johnson never die? Here’s all about tech entrepreneur’s tall claim, Bryan AI and Project BlueprintWill Bryan Johnson never die? Tech entrepreneur makes a tall claim that he may never die. He is building a digital version of himself calle...
Doctor says she almost died at 39 but then reversed her age to 23. Check her biohacking routine for longer lifeDr Alka Patel, a 53-year-old GP from the UK, claims she has reversed her biological age to 23 using a six-step daily routine focused on lif...
NEET 2024: Even non-biology students can also become doctors. Here is howUnder the revised guidelines, candidates who have studied physics, chemistry, biology/biotechnology, along with English, as additional subj...
'Alien' bodies are real, have 'eggs' inside body: Mexican doctors reveals after examination of remainsMexican doctors have examined mysterious remains believed to be non-human beings, sparking speculation. The examination involved tests on t...
Why Kiran Mazumdar-Shaw wants this Pulitzer-winner's 'immaculately researched' book to be prescribed in every high schoolThe Biocon boss says this book inspires the reader to delve deeper into the mysteries of cellular science.
It can get really tough to teach science! Try art insteadArt works are a great way to raise children's interest in science.
Roche vs Indian Pharma: The battle for a cheaper cancer drugThe companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...
ET in the classroom: All you need to know about the emerging technology of bionicsThe emerging technology of bionics provides hope to millions around the world who cannot hear, see or move.
Organisms from Earth could survive on Mars: StudyMars could support life in the shape of methanogens, one of the simplest and oldest microorganisms found on Earth, a new study claims.
- Intas Pharmaceutical launches low cost drug 'Mabtas' for cancer treatment
Intas Pharmaceutical today said it has launched 'Mabtas' a new low cost drug for treating cancer in India.
- Regulatory hurdles in US, UK hamper diagnostics outsourcing
Outsourcing of diagnostics and lab-testing services to India has proved to be a non-starter as regulatory hurdles in US and UK make it mand...